OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid ยท OpenFeds ยท OpenSpending

ยฉ 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodologyโ€ขDownload Data
  1. Home
  2. Providers
  3. Annapath, Inc
๐Ÿ”ฌ
Organization

Annapath, Inc

NPI: 1366539595
Bowie, MD
10 years of data
Clinical Laboratory
$33.9M
Total Payments
210
Beneficiaries
653.6K
Services
2.81x
Markup Ratio

Peer Comparison

97th
percentile in specialty
This provider$33.9M
Specialty median$1.9M
Rank #230 of 232 in specialty

๐Ÿ“‹ Key Findings

1Billed $33.9M over 10 years
22.81x markup ratio (above median)
397th percentile in Clinical Laboratory by payments
47 procedures with >3x markup
โœ“ No flags detected

๐Ÿ”Ž Data Analysis

This provider's $33.9M in total Medicare payments ranks in the 97th percentile of Clinical Laboratory providers nationally.

Medicare payments to this provider grew 323% from 2014 to 2023.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid โ€” the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2014$150.81$48.633.10x$102.18$1.5M30.0K6
2015$147.39$46.923.14x$100.47$1.7M36.9K9
2016$150.24$50.502.98x$99.74$2.2M42.8K9
2017$150.30$47.863.14x$102.44$2.2M45.8K16
2018$145.15$47.173.08x$97.98$2.4M51.6K20
2019$151.01$50.333.00x$100.68$3.2M63.4K20
2020$143.06$53.022.70x$90.04$4.0M75.7K30
2021$140.45$55.282.54x$85.17$5.2M93.9K33
2022$144.99$54.522.66x$90.47$5.4M98.3K30
2023$142.91$53.422.68x$89.49$6.2M115.2K37

Top Procedures (20)

88305Pathology examination of tissue using a microscope, intermediate complexityโš  4.0x markup
$9.6M
269.2K services$35.72/svc3.99x markup
88313Special stained specimen slides to examine tissue including interpretation and report
$6.7M
106.0K services$63.43/svc2.04x markup
88342Special stained specimen slides to examine tissue, initial procedure
$6.6M
93.8K services$70.50/svc2.54x markup
88312Special stained specimen slides to identify organisms including interpretation and report
$5.4M
67.9K services$80.07/svc2.12x markup
88341Special stained specimen slides to examine tissue, each additional procedure
$3.3M
53.2K services$62.44/svc2.31x markup
G0416Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any methodโš  5.1x markup
$323.6K
1.3K services$252.85/svc5.13x markup
G0461Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain
$294.5K
4.8K services$60.85/svc2.72x markup
U00042019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r
$269.6K
3.2K services$84.16/svc2.38x markup
84153Psa (prostate specific antigen) measurement, totalโš  3.1x markup
$179.6K
9.3K services$19.26/svc3.12x markup
88304Pathology examination of tissue using a microscope, moderately low complexityโš  3.5x markup
$112.0K
3.6K services$31.01/svc3.51x markup
88173Evaluation of fine needle aspirate with interpretation and report
$104.4K
729 services$143.17/svc1.77x markup
G2023Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
$103.6K
4.4K services$23.42/svc2.05x markup
U0003Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-rโš  6.7x markup
$94.9K
1.3K services$74.58/svc6.70x markup
88112Cell examination of specimen, selective cellular enhancement technique
$94.1K
2.1K services$44.41/svc2.54x markup
88121Cell examination of urine, computer-assisted
$88.2K
225 services$392.08/svc2.04x markup
88120Cell examination of urine, manual
$84.4K
153 services$551.38/svc1.98x markup
87086Bacterial colony count, urineโš  3.6x markup
$72.4K
8.7K services$8.35/svc3.59x markup
U0005Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed withinโš  3.0x markup
$68.3K
2.7K services$24.93/svc3.02x markup
84403Testosterone (hormone) level, total
$48.1K
1.8K services$26.25/svc2.95x markup
G0462Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)
$37.3K
677 services$55.10/svc2.67x markup
Show detailed table โ–พ
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
88305Pathology examination of tissue using a microscope, intermediate complexity269.2K$9.6M$35.723.99x
88313Special stained specimen slides to examine tissue including interpretation and report106.0K$6.7M$63.432.04x
88342Special stained specimen slides to examine tissue, initial procedure93.8K$6.6M$70.502.54x
88312Special stained specimen slides to identify organisms including interpretation and report67.9K$5.4M$80.072.12x
88341Special stained specimen slides to examine tissue, each additional procedure53.2K$3.3M$62.442.31x
G0416Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method1.3K$323.6K$252.855.13x
G0461Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain4.8K$294.5K$60.852.72x
U00042019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r3.2K$269.6K$84.162.38x
84153Psa (prostate specific antigen) measurement, total9.3K$179.6K$19.263.12x
88304Pathology examination of tissue using a microscope, moderately low complexity3.6K$112.0K$31.013.51x
88173Evaluation of fine needle aspirate with interpretation and report729$104.4K$143.171.77x
G2023Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source4.4K$103.6K$23.422.05x
U0003Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r1.3K$94.9K$74.586.70x
88112Cell examination of specimen, selective cellular enhancement technique2.1K$94.1K$44.412.54x
88121Cell examination of urine, computer-assisted225$88.2K$392.082.04x
88120Cell examination of urine, manual153$84.4K$551.381.98x
87086Bacterial colony count, urine8.7K$72.4K$8.353.59x
U0005Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within2.7K$68.3K$24.933.02x
84403Testosterone (hormone) level, total1.8K$48.1K$26.252.95x
G0462Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)677$37.3K$55.102.67x

Markup Analysis

Charge-to-Payment Ratio

2.81x

This provider submits charges 2.81 times higher than what Medicare actually pays.

What This Means

A markup ratio of 2.81x means for every $100 Medicare pays, this provider initially charges $281. This is higher than the national average.

Location

Bowie, MD

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Similar Providers

Other Clinical Laboratory providers in MD for peer comparison.

Annapath, Inc (you)
$33.9M
Quest Diagnostics Incorporated Mdโš ๏ธ
$318.4M
Genedx Llc
$67.3M
Theranostix Inc
$61.4M
Realtox Labs, Llc
$53.6M
Cirrus Dx, Inc.
$37.3M
Show detailed table โ–พ
ProviderLocationTotal PaymentsStatus
Quest Diagnostics Incorporated MdBaltimore, MD$318.4Mโš ๏ธ Flagged
Genedx LlcGaithersburg, MD$67.3Mโœ“ Clear
Theranostix IncBeltsville, MD$61.4Mโœ“ Clear
Realtox Labs, LlcReisterstown, MD$53.6Mโœ“ Clear
Cirrus Dx, Inc.Rockville, MD$37.3Mโœ“ Clear

Related

Browse
โ† Back to Provider Directory
State
All providers in MD โ†’
Specialty
All Clinical Laboratory providers โ†’
Tool
Compare this provider โ†’
Analysis
Fraud Watchlist โ†’
Search
Search all providers โ†’

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • โ€ข Centers for Medicare & Medicaid Services (CMS)
  • โ€ข Medicare Provider Utilization and Payment Data (2014-2023)
  • โ€ข National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data